AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $41,253,000 | +49.4% | 1,786,637 | -8.6% | 0.25% | -31.8% |
| Q3 2020 | $27,611,000 | -1.5% | 1,955,474 | +5.2% | 0.37% | +70.4% |
| Q2 2020 | $28,039,000 | -99.8% | 1,859,320 | 0.0% | 0.22% | +33.3% |
| Q1 2020 | $16,473,575,000 | -9.0% | 1,859,320 | 0.0% | 0.16% | +33.9% |
| Q4 2019 | $18,109,777,000 | +121344.3% | 1,859,320 | 0.0% | 0.12% | +16.3% |
| Q3 2019 | $14,912,000 | -35.7% | 1,859,320 | 0.0% | 0.10% | -34.6% |
| Q2 2019 | $23,204,000 | -8.2% | 1,859,320 | 0.0% | 0.16% | -11.2% |
| Q1 2019 | $25,286,000 | +42.0% | 1,859,320 | 0.0% | 0.18% | +18.5% |
| Q4 2018 | $17,812,000 | -20.8% | 1,859,320 | 0.0% | 0.15% | -6.2% |
| Q3 2018 | $22,478,000 | -22.6% | 1,859,320 | 0.0% | 0.16% | -29.7% |
| Q2 2018 | $29,042,000 | +10.3% | 1,859,320 | 0.0% | 0.23% | +11.7% |
| Q1 2018 | $26,327,000 | -1.6% | 1,859,320 | 0.0% | 0.20% | -28.1% |
| Q4 2017 | $26,756,000 | – | 1,859,320 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,114,043 | $116,817,000 | 7.46% |
| Parametrica Management Ltd | 597,279 | $6,899,000 | 6.86% |
| Redmile Group, LLC | 22,716,086 | $262,371,000 | 5.96% |
| Perceptive Advisors | 53,118,886 | $613,524,000 | 4.73% |
| Asymmetry Capital Management, L.P. | 716,709 | $8,278,000 | 4.39% |
| CM Management, LLC | 450,000 | $5,198,000 | 3.93% |
| Avoro Capital Advisors LLC | 18,500,000 | $213,675,000 | 3.64% |
| Kynam Capital Management, LP | 573,699 | $6,626,000 | 3.54% |
| SECTORAL ASSET MANAGEMENT INC | 1,242,882 | $14,355,000 | 2.16% |
| Ghost Tree Capital, LLC | 500,000 | $5,775,000 | 2.07% |